By Dennis Thompson HealthDay ReporterWEDNESDAY, May 20, 2026 (HealthDay News) — Some people with sleep apnea might be able to ...
A once-nightly oral pill helped control obstructive sleep apnea in a large, Phase III clinical trial presented at the 2026 ...
New research shows Ozempic may reduce sleep apnea severity by over 50%. Here's what the science actually says.
Standard treatment for obstructive sleep apnea has long relied on continuous positive airway pressure machines, but new ...
May 18 (Reuters) - Privately held biotech firm Apnimed said on Monday its experimental pill for a sleep disorder met the main goal in a late-stage trial, potentially offering a convenient alternative ...
Having both OSA and insomnia makes treatment more complex. Learn why addressing both is critical for heart health and how CBTi can help you stick to CPAP.
New research shows GLP-1 drugs like Ozempic may reduce sleep apnea severity — here's what the latest science says ...
Wearables like the Apple Watch and Oura Smart Ring often have substantial positive impacts on the health and fitness ...
AD109, an investigational once-daily oral combination of aroxybutynin and atomoxetine, significantly improved airway ...
Share on Pinterest Could obstructive sleep apnea affect a person’s cognitive function? Image credit: Enes Evren/Getty Images. Obstructive sleep apnea is the most common type of sleep-breathing ...
Researchers recently tested a medicine called AD109 in a large phase 3 clinical trial and found encouraging results. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results